SCHEMBL25624653

SCHEMBL25624653

c1ccc(-c2c3ccccc3c(-c3cccc(-c4cccc5ccccc45)c3)c3ccc(-c4cccc5oc6ccccc6c45)cc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.39
▸ ACMSD Q8TDX5 1/20 0.39
▸ PLA2G2A P14555 3/20 0.37
▸ PLA2G4A P47712 3/20 0.37
▸ PLA2G10 O15496 1/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ ALOX5 P09917 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ ATM Q13315 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25624631 1.00 MCL1 (0.39) MCL1ACMSDPLA2G2APLA2G4APLA2G10
SCHEMBL25624630 0.96 MCL1 (0.39) MCL1ACMSDPLA2G2APLA2G4APLA2G10
SCHEMBL18272739 0.94 MCL1 (0.36) MCL1ACMSDPLA2G2APLA2G4APLA2G10
SCHEMBL25624612 0.94 MCL1 (0.39) MCL1ACMSDPLA2G2APLA2G4APLA2G10
SCHEMBL22936534 0.94 TDP1 (0.38) MCL1ACMSDPLA2G2APLA2G4APLA2G10
SCHEMBL23057121 0.94 MCL1 (0.39) MCL1ACMSDPLA2G2APLA2G4APLA2G10
SCHEMBL23955082 0.94 TDP1 (0.38) MCL1ACMSDPLA2G2APLA2G4APLA2G10
SCHEMBL22063083 0.94 CA12 (0.40) MCL1ACMSDPLA2G2APLA2G4ATDP1
SCHEMBL26404380 0.91 PLA2G2A (0.40) MCL1ACMSDPLA2G2APLA2G4APLA2G10
SCHEMBL23637540 0.91 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10ALOX5HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183200-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD (KR) 2023-06-15 — — US disclosed
US-20230183200-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD (KR) 2023-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183200-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME TRPA1, CRY2, SUN2 MCL1 1998/4885ACMSD 780/4885PLA2G2A 1982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback